Stromedix

Stromedix

Biomedical company focused on drugs for fibrosis, organ failure and cancer.

Launch date
Employees
Market cap
-
Enterprise valuation
€68m (Public information from Feb 2014)
Cambridge Massachusetts (HQ)
Authorizing premium user...